Expression level (2^-ΔCq) of microRNA in the hypothalamus of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Expanded heat maps showing the enriched pathways. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Expanded heat maps showing the enriched pathways. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Pathways with potential involvement of the target miRNAs. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Expression level (2^-ΔCq) of microRNA in the prefrontal cortex of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

Subjects:

The response of the <i>A</i>. <i>albopictus</i> larval Glutathione S-transferase (GST) enzyme increased 7.8-fold in response to <i>M</i>. <i>robertsii</i>-derived copper nanopartic... by Perumal Vivekanandhan (4863484)

Subjects:

TBSS results showing significant AxD and RD changes at baseline and the follow-up. by Sewon Lim (21989785)

“…<p>The regions indicated in green represent the mean white matter skeleton, whereas the regions indicated in red represent the regions with increased AxD (first row) and RD (second row). The decreased diffusivity metrics (AxD and RD) exhibited no statistically significant differences at <i><i>P</i></i> < 0.05 after correcting for multiple comparisons (FWE). …”

Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

Group control-after intervention. by Nan Tang (642590)

Subjects:

Group SFA-before intervention. by Nan Tang (642590)

Subjects:

Lost cases. by Nan Tang (642590)

Subjects:

Baseline sociodemographic data and disease-related variables of two groups (n = 105). by Nan Tang (642590)

Subjects:

Analysis of SAS, SDS, PSQI, and FertiQoL scores. by Nan Tang (642590)

Subjects:

Regression analysis of the relationship between intervention and anxiety, depression, sleep quality, quality of life, and clinical pregnancy rate. by Nan Tang (642590)

Subjects:

Group control-before intervention. by Nan Tang (642590)

Subjects:

Patient satisfaction with SFA intervention(%). by Nan Tang (642590)

Subjects:

Pre-Experiment. by Nan Tang (642590)

Subjects:

Between-group comparison of clinical pregnancy rate after intervention(%). by Nan Tang (642590)

Subjects:

Group SFA-after intervention. by Nan Tang (642590)

Subjects:

Intervention process of two groups. by Nan Tang (642590)

Subjects: